153 related articles for article (PubMed ID: 34214702)
1. Metabolic syndrome and colorectal adenoma risk: A systematic review and meta‑analysis.
Wu H; Zhang J; Zhou B
Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101749. PubMed ID: 34214702
[TBL] [Abstract][Full Text] [Related]
2. Central obesity and atherogenic dyslipidemia in metabolic syndrome are associated with increased risk for colorectal adenoma in a Chinese population.
Liu CS; Hsu HS; Li CI; Jan CI; Li TC; Lin WY; Lin T; Chen YC; Lee CC; Lin CC
BMC Gastroenterol; 2010 May; 10():51. PubMed ID: 20507579
[TBL] [Abstract][Full Text] [Related]
3. Gender difference in metabolic syndrome and incident colorectal adenoma: A prospective observational study (KCIS No.42).
Ku MS; Chiu SY; Chien KL; Lee YC; Chen SL; Chen CD
Medicine (Baltimore); 2021 Jun; 100(22):e26121. PubMed ID: 34087861
[TBL] [Abstract][Full Text] [Related]
4. Elevated Neutrophil-to-Lymphocyte Ratio in Metabolic Syndrome Is Associated with Increased Risk of Colorectal Adenoma.
Kim JH; Cho KI; Kim YA; Park SJ
Metab Syndr Relat Disord; 2017 Oct; 15(8):393-399. PubMed ID: 28910195
[TBL] [Abstract][Full Text] [Related]
5. Metabolic syndrome and the risk of colorectal cancer: a systematic review and meta-analysis.
Shen X; Wang Y; Zhao R; Wan Q; Wu Y; Zhao L; Wu X
Int J Colorectal Dis; 2021 Oct; 36(10):2215-2225. PubMed ID: 34331119
[TBL] [Abstract][Full Text] [Related]
6. The association between metabolic syndrome and colorectal neoplasm: systemic review and meta-analysis.
Jinjuvadia R; Lohia P; Jinjuvadia C; Montoya S; Liangpunsakul S
J Clin Gastroenterol; 2013 Jan; 47(1):33-44. PubMed ID: 23090040
[TBL] [Abstract][Full Text] [Related]
7. The association of Metabolic Syndrome and its Components with the Incidence and Survival of Colorectal Cancer: A Systematic Review and Meta-analysis.
Han F; Wu G; Zhang S; Zhang J; Zhao Y; Xu J
Int J Biol Sci; 2021; 17(2):487-497. PubMed ID: 33613107
[No Abstract] [Full Text] [Related]
8. Systematic review and meta-analysis: Associations between metabolic syndrome and colorectal neoplasia outcomes.
Lu L; Koo S; McPherson S; Hull MA; Rees CJ; Sharp L
Colorectal Dis; 2022 Jun; 24(6):681-694. PubMed ID: 35156283
[TBL] [Abstract][Full Text] [Related]
9. Abdominal obesity, glucose intolerance and decreased high-density lipoprotein cholesterol as components of the metabolic syndrome are associated with the development of colorectal cancer.
Choi YJ; Lee DH; Han KD; Shin CM; Kim N
Eur J Epidemiol; 2018 Nov; 33(11):1077-1085. PubMed ID: 30196334
[TBL] [Abstract][Full Text] [Related]
10. Association between metabolic syndrome and early-stage colorectal cancer.
Zhang C; Zhang L; Tian Y; Guan B; Li S
BMC Cancer; 2023 Oct; 23(1):1020. PubMed ID: 37872512
[TBL] [Abstract][Full Text] [Related]
11. Metabolic syndrome and liver-related events: a systematic review and meta-analysis.
Ren H; Wang J; Gao Y; Yang F; Huang W
BMC Endocr Disord; 2019 Apr; 19(1):40. PubMed ID: 31023282
[TBL] [Abstract][Full Text] [Related]
12. Metabolic syndrome is an independent risk factor for synchronous colorectal neoplasm in patients with gastric neoplasm.
Park W; Lee H; Kim EH; Yoon JY; Park JC; Shin SK; Lee SK; Lee YC; Kim WH; Noh SH
J Gastroenterol Hepatol; 2012 Sep; 27(9):1490-7. PubMed ID: 22432868
[TBL] [Abstract][Full Text] [Related]
13. Helicobacter pylori infection concomitant with metabolic syndrome further increase risk of colorectal adenomas.
Lin YL; Chiang JK; Lin SM; Tseng CE
World J Gastroenterol; 2010 Aug; 16(30):3841-6. PubMed ID: 20698048
[TBL] [Abstract][Full Text] [Related]
14. The Metabolic Syndrome Is a Risk Factor for Breast Cancer: A Systematic Review and Meta-Analysis.
Zhao P; Xia N; Zhang H; Deng T
Obes Facts; 2020; 13(4):384-396. PubMed ID: 32698183
[TBL] [Abstract][Full Text] [Related]
15. Association of body fat distribution and metabolic syndrome with the occurrence of colorectal adenoma: A case-control study.
Liu ZH; Zhang GX; Zhang H; Jiang L; Deng Y; Chan FSY; Fan JKM
J Dig Dis; 2021 Apr; 22(4):222-229. PubMed ID: 33656773
[TBL] [Abstract][Full Text] [Related]
16. The metabolic syndrome and its components as prognostic factors in colorectal cancer: A meta-analysis and systematic review.
Lu B; Qian JM; Li JN
J Gastroenterol Hepatol; 2023 Feb; 38(2):187-196. PubMed ID: 36287138
[TBL] [Abstract][Full Text] [Related]
17. Association between metabolic syndrome and the risk of colorectal cancer: a prospective study in China.
Wang Z; Chen R; Zhang L; Chen Y; Li J; Li S; Xu L; Hu Y; Bai Y
Eur J Cancer Prev; 2024 Jul; 33(4):347-354. PubMed ID: 38375832
[TBL] [Abstract][Full Text] [Related]
18. The relationship between metabolic syndrome and the incidence of colorectal cancer.
Lee J; Lee KS; Kim H; Jeong H; Choi MJ; Yoo HW; Han TH; Lee H
Environ Health Prev Med; 2020 Feb; 25(1):6. PubMed ID: 32075578
[TBL] [Abstract][Full Text] [Related]
19. Colorectal cancer and its association with the metabolic syndrome: a Malaysian multi-centric case-control study.
Ulaganathan V; Kandiah M; Zalilah MS; Faizal JA; Fijeraid H; Normayah K; Gooi BH; Othman R
Asian Pac J Cancer Prev; 2012; 13(8):3873-7. PubMed ID: 23098486
[TBL] [Abstract][Full Text] [Related]
20. Association between nonalcoholic fatty liver disease and colorectal adenoma: a systemic review and meta-analysis.
Shen H; Lipka S; Kumar A; Mustacchia P
J Gastrointest Oncol; 2014 Dec; 5(6):440-6. PubMed ID: 25436123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
